Medibio Financial Statements From 2010 to 2025
| MDBIF Stock | USD 0.02 0.00 0.00% |
Check Medibio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medibio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medibio financial statements analysis is a perfect complement when working with Medibio Valuation or Volatility modules.
Medibio |
Medibio Limited Company Return On Asset Analysis
Medibio's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medibio Return On Asset | -0.13 |
Most of Medibio's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medibio Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medibio Limited has a Return On Asset of -0.1292. This is 98.52% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on asset for all United States stocks is 7.71% lower than that of the firm.
Medibio Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medibio's current stock value. Our valuation model uses many indicators to compare Medibio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medibio competition to find correlations between indicators driving Medibio's intrinsic value. More Info.Medibio Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medibio's earnings, one of the primary drivers of an investment's value.About Medibio Financial Statements
Medibio stakeholders use historical fundamental indicators, such as Medibio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medibio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medibio's assets and liabilities are reflected in the revenues and expenses on Medibio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medibio Limited. Please read more on our technical analysis and fundamental analysis pages.
Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia. Medibio operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Medibio Pink Sheet
Medibio financial ratios help investors to determine whether Medibio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medibio with respect to the benefits of owning Medibio security.